Article
Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia
1 Oct 2021
Abstract excerpt
Acute myeloid leukemia (AML) with MLL-rearrangement (MLL-r) comprises ∼10% of all AML cases and portends poor outcomes. Much remains uncovered on how MLL-r AML drives leukemia development while preventing cells from normal myeloid differentiation. Here, we identified that transcription factor MEF2D is a super-enhancer-associated, highly expressed gene in MLL-r AML. Knockout of MEF2D profoundly impaired leukemia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
